Dequalinium Chloride-An Emerging Option in the Sparse Landscape of Bacterial Vaginosis Therapies
JAMA Netw Open
.
2024 May 1;7(5):e248606.
doi: 10.1001/jamanetworkopen.2024.8606.
Authors
Kayla A Carter
1
2
,
Susan Tuddenham
3
,
Rebecca M Brotman
1
4
Affiliations
1
Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore.
2
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore.
3
Division of Infectious Diseases, Johns Hopkins University, Baltimore, Maryland.
4
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore.
PMID:
38696175
DOI:
10.1001/jamanetworkopen.2024.8606
No abstract available
MeSH terms
Adult
Anti-Bacterial Agents / therapeutic use
Female
Humans
Vaginosis, Bacterial* / drug therapy
Substances
Anti-Bacterial Agents
Grants and funding
T32 AI162579/AI/NIAID NIH HHS/United States
R01 AI167629/AI/NIAID NIH HHS/United States
R21 AI168984/AI/NIAID NIH HHS/United States
U54 EB007958/EB/NIBIB NIH HHS/United States
R01 DK130856/DK/NIDDK NIH HHS/United States
R01 AI182384/AI/NIAID NIH HHS/United States